Sana Biotechnology, Inc. (SANA) - Quarterly Income Statement

Home
SANA
Financials

2.66 (USD) • At close November 13, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1	2019 Q4
Revenue Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	161.527	0	0	0	0
Cost of Revenue Numbers are in millions	0	3.895	3.746	7.541	4.499	7.849	7.7	7.442	7.193	3.8	6.22	5.582	4.641	4.046	3.645	0	0	0	0	0
Gross Profit Numbers are in millions	0	-3.895	-3.746	-7.541	-4.499	-7.849	-7.7	-7.442	-7.193	-3.8	-6.22	-5.582	-4.641	-4.046	-3.645	161.527	0	0	0	0
Gross Profit Ratio Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0
Reseach & Development Expenses Numbers are in millions	47.709	36.299	89.071	48.541	-17.002	99.723	67.286	58.467	70.673	54.612	17.251	98.6	69.998	-31.029	168.93	104.117	44.545	81.897	27.32	39.274
General & Administrative Expenses Numbers are in millions	14.052	16.442	16.269	20.784	19.183	16.566	16.766	23.321	15.514	18.292	14.434	12.679	13.433	12.477	11.821	9.207	7.099	6.009	5.955	5.818
Selling & Marketing Expenses Numbers are in millions	0	-3.895	-3.746	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	14.052	12.547	12.523	20.784	19.183	16.566	16.766	23.321	15.514	18.292	14.434	12.679	13.433	12.477	11.821	9.207	7.099	6.009	5.955	5.818
Other Expenses Numbers are in millions	0	-4.121	0.215	-0.224	0.303	-0.084	-0.047	-0.268	-0.106	-0.198	-0.102	0.281	0.01	0.001	0.013	0.029	0.044	0.019	0.005	0.023
Operating Expenses Numbers are in millions	67.258	48.846	101.594	69.325	2.181	116.289	84.052	81.788	86.187	72.904	31.685	111.279	83.431	-18.552	180.751	113.324	51.644	87.906	33.275	45.092
Operating Income Numbers are in millions	-61.761	-52.741	-105.34	-76.866	-2.181	-116.289	-84.052	-81.788	-86.187	-72.904	-31.685	-111.279	-83.431	18.552	-180.751	-113.324	-51.644	-87.906	-33.275	-45.092
Operating Income Ratio Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-0.702	0	0	0	0
Total Other Income Expenses Net Numbers are in millions	1.837	-0.919	-2.135	-10.962	3.165	2.29	1.929	1.345	1.067	0.439	0.237	0.548	0.168	0.131	0.134	-35.967	0.192	0.098	0.4	-1.592
Income Before Tax Numbers are in millions	-59.924	-50.291	-107.475	-88.117	0.984	-113.999	-82.123	-80.443	-85.12	-72.465	-31.448	-110.731	-83.263	18.683	-180.617	-113.17	-51.452	-87.808	-32.875	-44.388
Income Before Tax Ratio Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-0.701	0	0	0	0
Income Tax Expense Numbers are in millions	0	0	3.703	7.497	-2.862	-6.822	-1.929	-2.021	-1.173	-0.637	-0.237	-3.602	-0.158	-0.13	-0.121	-1.88	-0.148	-0.079	-0.395	-1.343
Net Income Numbers are in millions	-59.924	-50.291	-107.475	-88.117	0.984	-113.999	-80.194	-78.422	-83.947	-71.828	-31.211	-110.731	-83.263	18.683	-180.617	-113.17	-51.452	-87.808	-32.875	-43.045
Net Income Ratio Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-0.701	0	0	0	0
EPS Numbers are in millions	-0.25	-0.21	-0.49	-0.45	0.005	-0.59	-0.42	-0.41	-0.44	-0.38	-0.17	-0.6	-0.46	0.1	-1.52	-0.65	-0.39	-0.67	-0.25	-0.33
EPS Diluted Numbers are in millions	-0.25	-0.21	-0.49	-0.45	0.005	-0.59	-0.42	-0.41	-0.44	-0.38	-0.17	-0.6	-0.46	0.09	-1.52	-0.65	-0.39	-0.67	-0.25	-0.33
EBITDA Numbers are in millions	-57.704	-46.396	-103.729	-80.576	2.318	-111.841	-79.706	-73.001	-77.927	-68.665	-28.071	-105.149	-78.622	18.552	-176.972	-110.054	-50.124	-86.525	-32.01	-44.064
EBITDA Ratio Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-0.702	0	0	0	0

Sana Biotechnology, Inc.

NASDAQ:SANA Add to watchlist

NASDAQ:SANA